After-hours movers: Gilead Sciences, HealthEquity, CARGO Therapeutics and more

Published 18/03/2025, 21:42
©  Reuters

After-hours movers:

Gilead Sciences (NASDAQ:GILD) fell over 3% after WSJ reported The Health and Human Services Department is weighing plans to drastically cut the federal government’s funding for domestic HIV prevention.

HealthEquity (HQY) fell 12% after it reported guidance that was below consensus. HealthEquity sees FY2026 EPS of $3.54-$3.74, versus the consensus of $3.76. HealthEquity sees FY2026 revenue of $1.28-1.305 billion, versus the consensus of $1.309 billion.

CARGO Therapeutics (CRGX) rose 14% after Board of Directors has made the decision to suspend development efforts of both CRG-023 and CARGO’s allogeneic platform and has appointed Anup Radhakrishnan as interim CEO to lead the Company through a reverse merger or other business combination. Accordingly, CARGO has engaged TD Cowen as the Company’s exclusive strategic financial advisor. In connection with today’s announcement, the Company is also further reducing its workforce by approximately 90%.

StoneCo (STNE) rose 9% after quarterly EPS topped consensus.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.